Inspiration Healthcare Group
plc
("Inspiration Healthcare", the "Company"
or the "Group")
Board
changes
Inspiration Healthcare Group plc
(AIM: IHC), the global medical technology company
pioneering best-in-class, specialist neonatal intensive care
medical devices, announces the retirement of Bob
Beveridge, Non-Executive Director ("NED") who is stepping down
after nine years in line with best practice. Bob will be
replaced as NED and Chair of the Audit Committee by Richard Jones.
The Board wish to thank Bob for his years of service and commitment
to Inspiration Healthcare during his tenure and are delighted to be
able to appoint Richard to the role. Both changes will come into
effect from 31 January 2025.
Richard is a seasoned healthcare and life
sciences professional with extensive experience as a board member
of publicly listed companies. He has spent more than 20 years
serving in both independent NED and Executive Director roles and
has acted as a key adviser across a diverse range of public and
private companies in the life sciences space. He has expertise
across a wide spectrum of Board issues and has worked extensively
outside the UK PLC market having completed a US reverse merger as
CFO for a UK biotech company in 2019.
Currently he is a Senior Independent Director
and Audit Committee Chair of Alliance Pharma PLC, an AIM listed
international consumer healthcare company where he is closely
involved in all aspects of the business. Formerly, he was Chief
Financial Officer ("CFO") and Company Secretary of the UK and
Ireland's leading supplier of tele-radiology services, Medica Group
Ltd. His CFO and Board experience also includes Mereo Biopharma PLC
and Shield Therapeutics PLC.
Roy
Davis, Executive Chairman of Inspiration Healthcare
said: "We are delighted to welcome Richard on board,
and we are excited to be able to tap into his extensive capital
markets experience, as well as his in-depth knowledge of the US
market where we continue to grow our presence.
"On behalf of the Board, I would like to thank Bob for his
dedication and commitment to Inspiration Healthcare over almost a
decade. We will be sad to see him go, and we wish him all the very
best for his future plans."
Bob
Beveridge, outgoing Non-Executive Director
said: "I have thoroughly enjoyed my
time with the Inspiration Healthcare team over the years. I believe
they are at a key transitional phase, and I know they will be a
great success. I wish them well for a bright future."
Richard Jones,
incoming Non-Executive Director
added: "I am looking forward to joining the Board of Inspiration
Healthcare and sharing my PLC and life sciences industry expertise
with the team."
In accordance with Schedule 2 (g) of
the AIM Rules for Companies, Richard Crispin Morgan Jones (aged 58
years) holds / has held the following directorships/partnerships in
the last five years:
Current directorships / partnerships
|
Previous directorships / partnerships in last 5
years
|
Alliance Pharma plc
|
Global Diagnostics Ireland
Ltd
|
C4X Discovery Holdings
Limited
|
Global Retinopathy Screening
Ltd
|
Hampshire Topco Limited
|
JCA Seminars Limited
|
Hero Acquisitions Limited
|
Medica Australia Pty Ltd
|
HSS Hire Group plc
|
Medica Group Limited
|
HSS Hire Service Finance
Limited
|
Medica IT Services
Limited
|
RCMJ Consultancy Ltd
|
Medica Reporting Finance
Limited
|
|
Medica Reporting Limited
|
|
Medica Reporting Services
Limited
|
|
Medica US Inc
|
|
Med-IDX Pty Ltd
|
|
Med-IDX UK Limited
|
|
Mereo Biopharma 1 Limited
|
|
Mereo Biopharma 2 Limited
|
|
Mereo Biopharma 3 Limited
|
|
Mereo Biopharma 4 Limited
|
|
Mereo Biopharma Group plc
|
|
Mereo BioPharma Ireland
Limited
|
|
Mereo MereoCo Inc
|
|
Mereo US Holdings Inc
|
|
Moonlight Bidco Limited
|
|
Moonlight Midco 1 Limited
|
|
Moonlight Midco 2 Limited
|
|
Moonlight Topco Limited
|
Richard Crispin Morgan Jones does
not hold any ordinary shares in the capital of the Company.
There are no further disclosures to be made in accordance with AIM
Rule 17 or Schedule 2(g) of the AIM Rules for Companies.
For further
information, please contact:
Inspiration Healthcare Group plc
|
Tel: +44 (0)330 175 0000
|
Roy Davis, Executive
Chair
Alan Olby, Chief Financial
Officer
|
|
|
|
Panmure Liberum (Nominated Adviser &
Broker)
|
Tel: +44 (0)20 3100 2000
|
Richard Lindley
Will King
|
|
|
|
Walbrook PR
Ltd (Media and Investor Relations)
|
Tel: +44 (0)20 7933
8780 or
inspirationhealthcare@walbrookpr.com
|
Anna Dunphy
|
Mob: +44 (0) 7876 741
001
|
Louis Ashe-Jepson
|
Mob: +44 (0) 7747 515
393
|
About Inspiration Healthcare
Inspiration Healthcare (AIM: IHC)
designs, manufactures and markets pioneering medical
technology. Based in the UK, the Company specialises in neonatal
intensive care medical devices, which are addressing a critical
need to help to save the lives and improve the outcomes of
patients, starting with the very first breaths of life.
The Company has a broad portfolio of its own
products and complementary distributed
products, for use in neonatal intensive care designed
to support even the most premature babies throughout their hospital
stay. Its own branded products range from highly sophisticated
capital equipment such as ventilators for life support through to
single-use disposables.